Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Good luck
3CL Protease inhibitor and end of pandemics.
https://erictopol.substack.com/p/why-paxlovid-is-a-just-in-time-breakthrough?s=09
We just need $10 billions that are translated into $10 per share.
It will hold above 6. So many people are waiting for this dip buying opportunity. I moved some of my profit from AxxA, icoa, enga,alpp to here today and added another 450ks.
Very likely but I anticipate a buyout by Merck or other big Pharmas.
Luck you. I added between 6.6 and 7.2 cents today.
Looks good and hold strong.
I have a lot here. Buy and hold since early Oct
Agree, need to load as many shares as possible. Likely dollarland ahead.
No, should hold and this will be in multidollar territory.
Very positive Twitter messenger from Gerald.
#Tollovir coming right behind it, with natural 3CLpro & anti-cytokine dual mechanism to help hospitalized patients and then move upstream moderate and pediatric because very very safe. Ph2 data coming next few weeks Also looking at Long COVID. $TOMDF
— Gerald Commissiong (@G_Commish) December 13, 2021
Yes, hard to find gem in OTC land.
I don't play chart but fundamental. Did a lot DD and it is anticovid drug and potential multibillion MC soon.
Pfizer's Paxlovid increases $20 billions in valuation and even Tollovir in half of that, that should put SP in $10 territory.
Yes, keep loading from 3 cents and changed to bigger boats a few times
Smash the wall of 8
Release of Phase 2 data will drive SP over $1 or much higher. Keep adding daily.
That sounds OK for me even I think it should worth at least $10.
Soon it will blow up your chart
Phase 2 data could be released any time from now on and SP can be easily spiked over $1. It is very dangerous to flip stock at this moment and I hold firmly now.
I anticipate a great phase 2 data because there is no reason that Tollovir does not work based on science , phase 1 data and Pfizer's data.
Made a huge mistake when using stop loss 20 years ago. Bought 2000 shares of price line at $1.47 in my IRA account and was thought to hold for a long haul. But somehow set up a stop loss at $1.30 and was out when dropped to $1.34. 15 years late, price line traded over $1,500 per share. I still have a heart attach when thought about huge mistake I made.
Now plan to hold tomdf for a long haul.
You are right! Did you load some at 4s? I did add some.
Let's go and we need to march to dollarland.
Things are brewing. I wish I loaded more at 40s yesterday
It is good time to scoop cheap shares. Phase 2 data could be released anytime from now on.
You mean 16 cents coming?
Clinical trial data is key factor to drive SP. If coming phase 2 data is as great as phase 1, SP will go much higher and big pharma like Merck may either buy out or involve in further drug trial and development. From what I understand science behind, phase 1 data and Pfizer's data, i anticipate Tollovir works effectively in phase 2 trial. Need to be patient here.
Folks want cheap shares. Stock was heavily bashed @3, 4 cent range and I kept loading then. Feel sorry for those who sold me shares at 3, 4 cents.
Promising stock and every dip is opportunity for adding. I won't sell single shares until multi-dollars.
Like this statement in today's release:
----"Tollovir will be developed for the treatment of hospitalized COVID-19 (severe and critical), moderate COVID-19, long-haul COVID and potentially pediatric COVID-19"----.
Hope they will update phase 2 clinical trial data tomorrow.
Officially now they prepare for 2/3 trials for hospitalized and non-hospitalized patients in Israel.
“The Company’s proprietary therapeutic candidate Tollovir™ is currently in a Phase 2 clinical trial to treat hospitalized COVID-19 patients in Israel, and is preparing to initiate Phase 2/3 clinical trials for both hospitalized and non-hospitalized patients in Israel”.
Looks entire market is in dark red today.
I guess not. If result were not good, Gerald would not post or keep posting on Twitter.
Run out dry powder now. It is really cheap now. Try to liquidate other stocks and coins and add tomorrow morning.
Look for update soon
Stellar data released or updated tomorrow will blow up technical chart. This is a bio stock and SP is driving by Drug potential or trial data.
It will close green today
Grabbed some under 6
Silly, this could run to multi-dollar territory. I would hold for a while and market is huge as covid will coexist with us for a long time. Tollovid/Tollovir will gain popularity around the World.
looks 3CL protease is highly conserved among Coronavirus. Recent study shows it is much less frequently mutated and its function is, unlike S proten or gene, also highly tolerant to mutation. It is an ideal target for treatment of Covid. 3CL protease is a bad actor that targets and cleaves cellular proteins and causes various but serious side effect of infection. That is why so far only drugs that target 3CL protease achieve better success rate.